254 related articles for article (PubMed ID: 31412254)
1. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Matrix Proteolysis.
Baker-Williams AJ; Hashmi F; Budzyński MA; Woodford MR; Gleicher S; Himanen SV; Makedon AM; Friedman D; Cortes S; Namek S; Stetler-Stevenson WG; Bratslavsky G; Bah A; Mollapour M; Sistonen L; Bourboulia D
Cell Rep; 2019 Aug; 28(7):1894-1906.e6. PubMed ID: 31412254
[TBL] [Abstract][Full Text] [Related]
2. Methods to Assess the Impact of Hsp90 Chaperone Function on Extracellular Client MMP2 Activity.
Votra SD; Alsalih D; Bourboulia D
Methods Mol Biol; 2023; 2693():221-232. PubMed ID: 37540438
[TBL] [Abstract][Full Text] [Related]
3. p23 and Aha1: Distinct Functions Promote Client Maturation.
Biebl MM; Buchner J
Subcell Biochem; 2023; 101():159-187. PubMed ID: 36520307
[TBL] [Abstract][Full Text] [Related]
4. Integration of the accelerator Aha1 in the Hsp90 co-chaperone cycle.
Li J; Richter K; Reinstein J; Buchner J
Nat Struct Mol Biol; 2013 Mar; 20(3):326-31. PubMed ID: 23396352
[TBL] [Abstract][Full Text] [Related]
5. Targeting extracellular Hsp90: A unique frontier against cancer.
Sager RA; Khan F; Toneatto L; Votra SD; Backe SJ; Woodford MR; Mollapour M; Bourboulia D
Front Mol Biosci; 2022; 9():982593. PubMed ID: 36060252
[TBL] [Abstract][Full Text] [Related]
6. c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells.
Dunn DM; Woodford MR; Truman AW; Jensen SM; Schulman J; Caza T; Remillard TC; Loiselle D; Wolfgeher D; Blagg BS; Franco L; Haystead TA; Daturpalli S; Mayer MP; Trepel JB; Morgan RM; Prodromou C; Kron SJ; Panaretou B; Stetler-Stevenson WG; Landas SK; Neckers L; Bratslavsky G; Bourboulia D; Mollapour M
Cell Rep; 2015 Aug; 12(6):1006-18. PubMed ID: 26235616
[TBL] [Abstract][Full Text] [Related]
7. Aha1 can act as an autonomous chaperone to prevent aggregation of stressed proteins.
Tripathi V; Darnauer S; Hartwig NR; Obermann WM
J Biol Chem; 2014 Dec; 289(52):36220-8. PubMed ID: 25378400
[TBL] [Abstract][Full Text] [Related]
8. Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer.
Hance MW; Dole K; Gopal U; Bohonowych JE; Jezierska-Drutel A; Neumann CA; Liu H; Garraway IP; Isaacs JS
J Biol Chem; 2012 Nov; 287(45):37732-44. PubMed ID: 22989880
[TBL] [Abstract][Full Text] [Related]
9. Detection and Analysis of Extracellular Hsp90 (eHsp90).
Cortes S; Baker-Williams AJ; Mollapour M; Bourboulia D
Methods Mol Biol; 2018; 1709():321-329. PubMed ID: 29177669
[TBL] [Abstract][Full Text] [Related]
10. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
[TBL] [Abstract][Full Text] [Related]
11. A chemical compound inhibiting the Aha1-Hsp90 chaperone complex.
Stiegler SC; Rübbelke M; Korotkov VS; Weiwad M; John C; Fischer G; Sieber SA; Sattler M; Buchner J
J Biol Chem; 2017 Oct; 292(41):17073-17083. PubMed ID: 28851842
[TBL] [Abstract][Full Text] [Related]
12. Dynamic Aha1 co-chaperone binding to human Hsp90.
Oroz J; Blair LJ; Zweckstetter M
Protein Sci; 2019 Sep; 28(9):1545-1551. PubMed ID: 31299134
[TBL] [Abstract][Full Text] [Related]
13. A novel C-terminal homologue of Aha1 co-chaperone binds to heat shock protein 90 and stimulates its ATPase activity in Entamoeba histolytica.
Singh M; Shah V; Tatu U
J Mol Biol; 2014 Apr; 426(8):1786-98. PubMed ID: 24486610
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding of kinase and non-kinase clients.
Woodford MR; Sager RA; Marris E; Dunn DM; Blanden AR; Murphy RL; Rensing N; Shapiro O; Panaretou B; Prodromou C; Loh SN; Gutmann DH; Bourboulia D; Bratslavsky G; Wong M; Mollapour M
EMBO J; 2017 Dec; 36(24):3650-3665. PubMed ID: 29127155
[TBL] [Abstract][Full Text] [Related]
15. Extracellular roles for the molecular chaperone, hsp90.
Eustace BK; Jay DG
Cell Cycle; 2004 Sep; 3(9):1098-100. PubMed ID: 15326368
[TBL] [Abstract][Full Text] [Related]
16. Hsp90 C-terminal inhibitors exhibit antimigratory activity by disrupting the Hsp90α/Aha1 complex in PC3-MM2 cells.
Ghosh S; Shinogle HE; Garg G; Vielhauer GA; Holzbeierlein JM; Dobrowsky RT; Blagg BS
ACS Chem Biol; 2015 Feb; 10(2):577-90. PubMed ID: 25402753
[TBL] [Abstract][Full Text] [Related]
17. Biological and structural basis for Aha1 regulation of Hsp90 ATPase activity in maintaining proteostasis in the human disease cystic fibrosis.
Koulov AV; LaPointe P; Lu B; Razvi A; Coppinger J; Dong MQ; Matteson J; Laister R; Arrowsmith C; Yates JR; Balch WE
Mol Biol Cell; 2010 Mar; 21(6):871-84. PubMed ID: 20089831
[TBL] [Abstract][Full Text] [Related]
18. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
[TBL] [Abstract][Full Text] [Related]
19. Hsp90 middle domain phosphorylation initiates a complex conformational program to recruit the ATPase-stimulating cochaperone Aha1.
Xu W; Beebe K; Chavez JD; Boysen M; Lu Y; Zuehlke AD; Keramisanou D; Trepel JB; Prodromou C; Mayer MP; Bruce JE; Gelis I; Neckers L
Nat Commun; 2019 Jun; 10(1):2574. PubMed ID: 31189925
[TBL] [Abstract][Full Text] [Related]
20. Silencing of HSP90 cochaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin.
Holmes JL; Sharp SY; Hobbs S; Workman P
Cancer Res; 2008 Feb; 68(4):1188-97. PubMed ID: 18281495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
